The statistical analysis conducted in this study reveals the potential of using CID incorporated with correlation test to identify ER-regulated gene sets in silico and then to construct a two-layer regulatory network based on clinical breast cancer gene expression arrays. This evidence concerns the gene ESR1 and breast cancer.